# TB Biosciences, Inc. — Form D

TB Biosciences, Inc. of BETHLEHEM, PA, a company, filed a Form D exempt-offering notice with the SEC on 2013-06-12. The offering totals $1.5M, of which $1.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2013-06-12
- Form: D
- Accession: 0001578956-13-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $1.5M
- Amount sold: $1.3M
- Remaining: $250K
- Investors: 9
- Date of first sale: 2013-05-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-197829

## Issuer

- Name: TB Biosciences, Inc.
- CIK: 0001578956
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 205 WEBSTER STREET, BETHLEHEM, PA, 18015
- Phone: 610-597-5501

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| MICHAEL SAM GAUSLING | Director | BETHLEHEM, PA |
| R. SAM NIEDBALA | Director | BETHLEHEM, PA |
| DAVID SAM OXELY | Director | BETHLEHEM, PA |
| R. SAM NIEDBALA | Executive Officer | BETHLEHEM, PA |

## More

- [CIK 1578956 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1578956&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001578956-13-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.